Lundbeckfonden Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Copenhagen, CR Denmark
Total Funding:N/A
Industry:NonProfit
Founded:1954
Lead Investor(s):N/A
Press
Claim your profile

Employee Data

  • Lundbeckfonden has 40 Employees.
  • Lundbeckfonden grew their employee count by 25% last year.
  • Lundbeckfonden currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Lundbeckfonden
N/A4025%N/A
Missing a competitor? Contribute!?
Submit

The Lundbeck Foundation is an active industrial Foundation. Hans Lundbeck founded the company H. Lundbeck in 1915. In 1954, his widow, Grete Lundbeck, established the Lundbeck Foundation and transferred her shares in H. Lundbeck to the Foundation as the couple had no heirs. Today H. Lundbeck is a world leader in the development and sales of drugs to treat brain disorders, and the Foundation owns 70% of the company. In 1989 The Lundbeck Foundation acquired its second subsidiary, and today owns 40% of the capital (67% of the votes) in ALK, the world leader in allergy vaccines. In 2011, the Foundation bought 57% of the leading international rescue and assistance company, Falck. In addition to the three subsidiaries, the Foundation owns and manages a portfolio worth approx. DKK 13,9 billion via Lundbeckfonden Invest, as well as a portfolio of biotech investments managed by Lundbeckfonden Ventures. Lundbeckfonden Emerge, is a strategic initiative to accelerate commercialization of early scientific opportunities through investment and active project involvement. The Foundation annually grants DKK 400-500 million to independent scientific research of the highest international quality. Euro 1 million goes to "The Brain Prize" awarded by Grete Lundbeck's European Brain Research Foundation. It is the Foundation's vision to create better lives through new knowledge.

keywords:N/A

40

Number of Employees

N/A

Revenue (est)

1

Current Jobs

25%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Lundbeckfonden News

12-Sep-19 - Biopharmaceutical Company Imara Inc. Files Confidentially for ...

... with participation from RA Capital, Rock Springs Capital, Alexandria Venture Investments, Bay City Capital, Lundbeckfonden Ventures, New ...

24-Jun-19 - AFYX Therapeutics Closes $13 Million Convertible Loan Financing

Sofinnova Ventures led the investment, with Novo Seeds and Lundbeckfonden Emerge also participating. Proceeds will be used to support the ...

11-Mar-19 - Denmark's SNIPR Biome Launches to Merge CRISPR With ...

The financing was led by existing investor Lundbeckfonden Emerge in Copenhagen and LSP in Amsterdam, along with North-East Family ...